Therapeutic Metabolic Intervention in Patients With Spastic Paraplegia SPG5
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 18 Feb 2017
At a glance
- Drugs Atorvastatin (Primary) ; Chenodeoxycholic acid (Primary) ; Resveratrol
- Indications Paraplegia
- Focus Therapeutic Use
- Acronyms SPA-M
- 03 Mar 2016 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 24 Feb 2016 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.
- 19 Dec 2014 New trial record